The Lindner Research Center

Cincinnati, Ohio 45219-2906

5 studies enrolling now · 26 studies all time

What they study most

Alzheimer Disease, Aortic Aneurysm, Aortic Dissection, Atrial Fibrillation, CIED Related Infection, Cardiac Pacemaker, Artificial, Cardiovascular Disease, Cardiovascular Disease With Mention of Arteriosclerosis, Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Stroke, Coronary Artery Disease

Studies at this site

• STOP AF First Post-Approval Study — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• Prevail Global Study — Recruiting now
• NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness — Recruiting now
• STOP Persistent AF PAS — Running, not enrolling
• Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) — Completed
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
• Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
• Cryo Global Registry — Completed
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction — Enrolling by invitation
• REmodeling the Left Ventricle With Atrial Modulated Pacing — Completed
• A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4 — Completed
• Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction — Status unconfirmed
• Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction — Status unconfirmed
• AdaptResponse Clinical Trial — Completed
• Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients — Completed
• Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Attain Stability™ Quad Clinical Study — Completed
• Reveal LINQ™ Heart Failure — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Pressure Variability Study — Completed
• Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction — Completed
• Advisa MRI Clinical Study — Completed